Journal article icon

Journal article

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.

Abstract:

Background

Regional differences in risk of diabetes mellitus and cardiovascular outcomes in people with impaired glucose tolerance are poorly characterized. Our objective was to evaluate regional variation in risk of new-onset diabetes mellitus, cardiovascular outcomes, and treatment effects in participants from the NAVIGATOR (Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research) trial.

Methods and Results

NAVIGATOR randomized people with impa...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1161/JAHA.116.003892

Authors


Publisher:
American Heart Association
Journal:
Journal of the American Heart Association More from this journal
Volume:
6
Issue:
1
Pages:
e003892
Publication date:
2017-01-01
Acceptance date:
2016-09-29
DOI:
EISSN:
2047-9980
Language:
English
Keywords:
Pubs id:
pubs:671819
UUID:
uuid:f5b28db6-aae3-47cd-8bb8-f6ac45f9a6d4
Local pid:
pubs:671819
Source identifiers:
671819
Deposit date:
2017-05-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP